DarioHealth (DRIO)
(Delayed Data from NSDQ)
$1.47 USD
-0.03 (-2.00%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $1.47 0.00 (0.00%) 5:32 PM ET
1-Strong Buy of 5 1
D Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for DarioHealth Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 37 | 50 | 36 | 29 | 21 |
Receivables | 5 | 8 | 3 | 3 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5 | 8 | 6 | 2 | 1 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 47 | 66 | 46 | 34 | 23 |
Net Property & Equipment | 1 | 1 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 47 | 52 | 54 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 96 | 119 | 101 | 35 | 25 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 2 | 5 | 2 | 2 |
Current Portion Long-Term Debt | 4 | 9 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 7 | 8 | 9 | 4 | 3 |
Total Current Liabilities | 12 | 19 | 14 | 7 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 25 | 18 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 1 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 38 | 39 | 15 | 7 | 6 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 408 | 366 | 308 | 171 | 129 |
Retained Earnings | -349 | -286 | -222 | -143 | -110 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 58 | 80 | 86 | 28 | 19 |
Total Liabilities & Shareholder's Equity | 96 | 119 | 101 | 35 | 25 |
Total Common Equity | 58 | 80 | 86 | 28 | 19 |
Shares Outstanding | 27.20 | 25.60 | 16.50 | 8.10 | 2.20 |
Book Value Per Share | 2.14 | 3.13 | 5.18 | 3.48 | 8.59 |
Fiscal Year End for DarioHealth Corp falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 37 | 44 | 53 | 43 |
Receivables | NA | 5 | 6 | 7 | 5 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5 | 5 | 6 | 7 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 47 | 56 | 66 | 55 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 47 | 48 | 49 | 50 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 96 | 107 | 117 | 108 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 2 | 1 | 2 |
Current Portion Long-Term Debt | NA | 4 | 0 | 0 | 9 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 7 | 6 | 6 | 7 |
Total Current Liabilities | NA | 12 | 8 | 8 | 18 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 25 | 29 | 29 | 17 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 38 | 38 | 39 | 36 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 408 | 402 | 395 | 371 |
Retained Earnings | NA | -349 | -334 | -317 | -299 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 58 | 68 | 78 | 72 |
Total Liabilities & Shareholder's Equity | NA | 96 | 107 | 117 | 108 |
Total Common Equity | 0 | 58 | 68 | 78 | 72 |
Shares Outstanding | 29.40 | 27.20 | 27.20 | 26.70 | 25.80 |
Book Value Per Share | 0.00 | 2.14 | 2.50 | 2.94 | 2.79 |